10-Q: Agape ATP Reports Wider Loss Amid Strategic Shift

Agape ATP Corporation reported a wider net loss for the second quarter and first half of 2025, despite revenue growth driven by new green energy and skincare segments, as it grapples with declining gross margins and significant internal control weaknesses.

Summary

• Net loss for the three months ended June 30, 2025, increased to $623,246 from $432,315 in the prior year period, a 44.2% increase.
• Net loss for the six months ended June 30, 2025, widened to $1,336,165 from $1,135,410 in the prior year period, a 17.7% increase.
• Total revenue for the three months ended June 30, 2025, increased by 48.7% to $465,499, primarily due to new revenue streams from green energy ($135,434) and skin care/healthcare products ($55,446).
• Total revenue for the six months ended June 30, 2025, increased by 19.4% to $754,536, also driven by new green energy ($136,999) and skin care/healthcare products ($64,125) segments.
• Gross margin decreased to 44.9% for the three months ended June 30, 2025, from 61.8% in the prior year, and to 48.4% for the six months ended June 30, 2025, from 62.8% in the prior year.
• Network marketing business revenue decreased by 44.8% for the three-month period and 35.6% for the six-month period.
• Revenue from complementary health therapies decreased by 8.9% for the three-month period and 9.7% for the six-month period, attributed to no overseas customers in 2025.
• Total operating expenses increased by 30.7% for the three-month period and 9.4% for the six-month period, mainly due to increased selling, commission, and general & administrative expenses related to new revenue streams.
• Cash and cash equivalents significantly decreased to $215,973 as of June 30, 2025, from $2,040,243 as of December 31, 2024.
• The company used $1,948,332 in cash from operating activities for the six months ended June 30, 2025.
• A significant advance of $23,000,000 was made for investment purposes to Bi Cheng Investment Management Limited, which remains unallocated to a specific investee as of the reporting date.
• The company raised $23,000,000 from the issuance of 46,000,000 common shares on March 20, 2025.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to significant and widening net losses, declining gross margins, and a prominent 'going concern' warning. While revenue growth from new segments and a large capital raise occurred, the capital was immediately deployed into an uncertain investment, and the company faces severe internal control weaknesses and liquidity challenges. The overall financial health and operational efficiency appear to be deteriorating.

Positives

• Total revenue increased by 48.7% for the three months ended June 30, 2025, and 19.4% for the six months ended June 30, 2025, driven by diversification into new segments.
• Successfully launched new revenue streams in green energy and skin care/healthcare products, contributing significantly to overall revenue.
• Completed a capital raise of $23,000,000 through common stock issuance, substantially improving working capital to $23,149,202 as of June 30, 2025.

Negatives

• Net loss widened significantly by 44.2% for the three-month period and 17.7% for the six-month period.
• Gross margin declined substantially from 61.8% to 44.9% for the quarter, and from 62.8% to 48.4% for the six-month period, indicating lower profitability on sales.
• Revenue from the core network marketing business and complementary health therapies segments decreased.
• Operating expenses increased significantly, outpacing revenue growth in some areas.
• Cash and cash equivalents saw a sharp decline, primarily due to a large investment advance.
• The company incurred an inventory write-off of $6,897 for the six months ended June 30, 2025.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring net losses and negative operating cash flows.
• The $23,000,000 deposit with Bi Cheng Investment Management Limited for future investment opportunities is uncertain regarding financial return and recoverability, especially given the legal, regulatory, and foreign exchange uncertainties in the PRC.
• Significant concentration of revenue from one major customer (29.1% for Q2 2025 revenue, 21.4% of accounts receivable).
• High concentration of purchases from a few major vendors (two vendors accounted for 86.9% of purchases in Q2 2025).
• Reliance on a few sales distributors for a significant portion of commission expenses (two distributors accounted for 58% in Q2 2025).
• Exposure to credit risk on cash deposits, accounts receivable, and prepayments, with $38,310 of cash not covered by deposit insurance.
• Foreign exchange rate fluctuations between USD, MYR, CNY, and HKD can adversely impact reported financial results.
• Material weaknesses in internal control over financial reporting, including insufficient accounting personnel, lack of a functional internal audit department, and inadequate procedures for assessing third-party manager credit risk for investments.

Future Outlook

The company is positioning itself for sustainable growth by diversifying into renewable energy and developing a digital wellness platform for the ASEAN market. However, the ability to continue as a going concern is dependent on increasing revenue, controlling operating costs, and successfully executing new investment opportunities to generate financial returns. There is no assurance that these plans will be successfully executed.

Management Comments

• "The decrease in revenue from the Company's network marketing business was due to a strategic shift in focus toward new revenue streams aimed at restoring growth and diversifying income sources."
• "Additionally, revenue from the Company's operations in the provision of complementary health therapies declined because, in 2025, the Company did not generate any revenue from overseas customers."
• "The Company is positioning itself for sustainable growth by diversifying its operations into the domain of renewable energy. This initiative is founded upon our commitment to environmental responsibility, long-term value creation, and proactive adaptation to global energy trends."
• "The Company believes these actions will improve the Company's financial position, However, there can be no assurance that these plans and arrangements can be successfully executed and the outcome of these plans are uncertain."

Industry Context

Agape ATP Corporation is diversifying its traditional health and wellness product and advisory services business, which includes network marketing and complementary health therapies, into the renewable energy sector and digital wellness platforms. This diversification aligns with broader industry trends towards sustainability and digital health solutions, potentially opening new growth avenues as traditional segments face challenges. The decline in network marketing and complementary health therapies revenue, particularly from overseas customers, suggests a need for this strategic pivot. The company's expansion into green energy and digital platforms indicates an attempt to capture market share in growing sectors, moving beyond its established, but currently declining, core businesses.

Comparison to Industry Standards

• The company's gross margin of 44.9% (Q2 2025) and 48.4% (H1 2025) is significantly lower than the 61.8% and 62.8% reported in the prior year periods, indicating a deterioration in product/service profitability. This decline is attributed to varying gross profit margins in complementary health therapies and low gross margins in the new green energy segment. In the health and wellness industry, gross margins can vary widely, but a substantial decline suggests competitive pressures or unfavorable product mix shifts.
• The company's continued net losses and negative operating cash flows, coupled with a 'going concern' warning, indicate performance significantly below industry standards for a healthy, growing company. While specific comparable companies are not named in the filing, sustained losses and liquidity concerns are red flags compared to profitable peers in the health, wellness, or renewable energy sectors.
• The significant investment of $23 million into an unidentified opportunity via a third-party manager (Bi Cheng Investment Management Limited) without an allowance for credit loss, and the stated 'uncertainty' of financial return, is a highly unusual and risky capital allocation strategy that deviates from prudent investment management practices seen in established companies.

Corporate Governance

Related Party Transactions

• Amount due from TH3 Holdings Sdn Bhd (TH3) for prepayment of IT expenses: $2,706 as of June 30, 2025.
• Amount due from ATPC Lega Global Sdn Bhd (Lega) for general expenses payment on behalf: $730 as of June 30, 2025.
• Accounts payable to CTA Nutriceuticals (Asia) Sdn Bhd (CTA) for product purchases: $29,755 as of June 30, 2025.
• Accounts payable to SY Welltech Sdn Bhd (Welltech) for beauty product purchases: $38 as of June 30, 2025.
• Accounts payable to Cedar Wellness Sdn Bhd (CW) for skin care and healthcare product purchases: $1,656 as of June 30, 2025.
• Other payable to CTA Nutriceuticals (Asia) Sdn Bhd (CTA) for general use products: $144 as of June 30, 2025.
• Other payable to Cedar Wellness Sdn Bhd (CW) for selling and event related expenses: $5,772 as of June 30, 2025.
• Other payable to Ms. Low Mui Chin (director of Cedar ATPC Sdn Bhd) for selling and event related expenses: $1,227 as of June 30, 2025.
• Other payable to Mr. How Kok Choong (CEO and director) for salary, commission, and borrowing: $230,249 as of June 30, 2025.
• Purchases from CTA Nutriceuticals (Asia) Sdn Bhd for complementary health therapies: $86,199 (Q2 2025) and $172,026 (H1 2025).
• Purchases from SY Welltech Sdn Bhd for beauty products: $96 (Q2 2025) and $150 (H1 2025).
• Purchases from Cedar Wellness Sdn Bhd for skin care and healthcare products: $10,000 (Q2 2025) and $10,000 (H1 2025).
• Other purchases from CTA Nutriceuticals (Asia) Sdn Bhd for general use: $648 (Q2 2025) and $2,129 (H1 2025).
• Other purchases from SY Welltech Sdn Bhd for general use: $0 (Q2 2025) and $1,151 (H1 2025).
• Commission expense paid to Mr. How Kok Choong: $372 (Q2 2025) and $766 (H1 2025).
• Rental income from TH3 Holdings Sdn Bhd: $207 (Q2 2025) and $414 (H1 2025).
• Rental income from Ando Design Sdn Bhd: $0 (Q2 2025) and $230 (H1 2025).
• IT support services fee to TH3 Holdings Sdn Bhd: $15,271 (Q2 2025) and $30,421 (H1 2025).
• Office rental expense to DSY Wellness and Longevity Center Sdn Bhd: $27,629 (Q2 2025) and $55,258 (H1 2025).
• Payment on behalf for selling and event related expenses to Cedar Wellness Sdn Bhd: $23,715 (Q2 2025) and $23,715 (H1 2025).

Stakeholder Impact

• **Shareholders:** Face significant risk due to widening net losses, declining gross margins, and a 'going concern' warning. The large capital raise was immediately tied to an uncertain investment, increasing risk exposure. The stock price is highly likely to be negatively impacted.
• **Employees:** The company's financial instability and 'going concern' warning could lead to job insecurity or reduced benefits, although the filing does not explicitly state this.
• **Customers:** Potential impact on product availability or service quality if financial difficulties persist, especially in the network marketing and complementary health therapies segments.
• **Suppliers/Vendors:** Concentration of purchases with a few vendors could pose risks if the company's financial health deteriorates, potentially affecting payment terms or future business relationships.
• **Creditors:** The 'going concern' warning and accumulated deficit indicate increased credit risk for any existing or potential creditors.

Next Steps

• Increase revenue and control operating costs to generate positive operating cash flow.
• Obtain additional financing from outside sources.
• Successfully identify and execute new investment opportunities to generate financial returns.
• Remediate identified material weaknesses in internal control over financial reporting by preparing written policies, establishing a formal monthly closing process, engaging a consulting firm, and initiating a comprehensive training program for accounting staff.
• Monitor the progress of the $23 million investment with Bi Cheng Investment Management Limited and reclassify the deposit as an investment asset upon transaction completion.

Key Dates

Recommendation

The company's financial performance is deteriorating, marked by widening net losses and a significant decline in gross margins. The 'going concern' warning is a critical red flag, indicating substantial doubt about its ability to continue operations. While a large capital raise occurred, the immediate deployment of $23 million into an uncertain investment with a third party in China, coupled with identified material weaknesses in internal controls, introduces severe unmitigated risks. The strategic shift into new segments has not yet translated into overall profitability, and the core businesses are declining. For a seasoned investor, these factors collectively point to a highly speculative and risky investment, warranting a strong sell recommendation to minimize potential losses.

Keywords

Health and Wellness, Renewable Energy, SEC Filing, 10-Q, Financial Results, Net Loss, Revenue Growth, Gross Margin, Operating Expenses, Cash Flow, Going Concern, Internal Controls, Investment Risk, Capital Raise, Malaysia, China, Network Marketing, Supplements, Digital Wellness Platform